SMB Luer lock disposable syringe

K231558 · Smb Corporation of India · FMF · Jan 12, 2024 · General Hospital

Device Facts

• Record ID: K231558
• Device Name: SMB Luer lock disposable syringe
• Applicant: Smb Corporation of India
• Product Code: FMF · General Hospital
• Decision Date: Jan 12, 2024
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 880.5860
• Device Class: Class 2
• Attributes: Therapeutic

Indications for Use

SMB Hypodermic Syringe is used to inject fluid into or withdraw fluid from the body. This device is for single use only.

Device Story

SMB Luer lock disposable syringe is a two-piece piston syringe with a male 6% luer lock connection, supplied with a 23G hypodermic needle featuring a female 6% luer hub. The device consists of a hollow polypropylene barrel with a graduated scale and a high-density polyethylene (HDPE) plunger. The needle assembly includes a stainless steel (SS304) tube, polypropylene hub, and HDPE protective cap. The device is sterilized via ETO gas. It is intended for single-use manual operation by healthcare professionals or patients to aspirate or inject fluids. The luer lock mechanism ensures a secure connection between the syringe and needle to prevent leakage or accidental detachment. The device is non-pyrogenic and biocompatible.

Clinical Evidence

No clinical data included. Bench testing only, including biocompatibility (ISO 10993), sterility (USP 32 NF27), bacterial endotoxin (USP 85), particulate contamination (USP 788), and mechanical performance (ISO 7864, ISO 7886-1, ISO 594-1/2).

Technological Characteristics

Piston syringe; 2ml volume; 23G needle. Materials: Polypropylene (barrel/hub), HDPE (plunger/cover), SS304 (needle). Luer-lock connection. Sterilization: ETO gas (SAL 10^-6). Standards: ISO 7886-1:2017, ISO 7864:2016, ISO 594-1/2, ISO 9626-2016, ISO 11607-1/2, ISO 11135:2014.

Indications for Use

Indicated for injection of fluid into or withdrawal of fluid from the body in patients requiring hypodermic syringe use. Single use only.

Regulatory Classification

Identification

A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.

Predicate Devices

• MiniLoad Syringe (K202432)
• Hypodermic Needle (K102584)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA acronym with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out to the right of the square.

January 12, 2024

SMB Corporation of India % Atonu Datta, CEO Alceon Medtech Consulting 1008, 10th Floor, "OCEAN", Sarabhai Compound Near Centre Square mall, Dr. V.S. Marg Vadodara, Gujarat 390023, India

#### Re: K231558

Trade/Device Name: SMB Luer lock disposable syringe Regulation Number: 21 CFR 880.5860 Regulation Name: Piston syringe Regulatory Class: Class II Product Code: FMF, FMF, FMI Dated: December 5, 2023 Received: December 11, 2023

#### Dear Atonu Datta:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

{1}------------------------------------------------

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

# Sincerely, Shruti N. Mistry -S

Shruti Mistry Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K231558

Device Name SMB Luer lock disposable syringe

Indications for Use (Describe)

SMB Hypodermic Syringe is used to inject fluid into or withdraw fluid from the body. This device is for single use only.

| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|

| <div style="display:flex; align-items:center;"> <span> <svg height="16" width="16"> <rect fill="white" height="16" stroke="black" stroke-width="1" width="16"></rect> <path d="M2,2 L14,14 M14,2 L2,14" stroke="black" stroke-width="2"></path> </svg> </span> <span>Residential (Part 9, OBC, M-1 Division)</span> </div> | <div style="display:flex; align-items:center;"> <span> <svg height="16" width="16"> <rect fill="white" height="16" stroke="black" stroke-width="1" width="16"></rect> </svg> </span> <span>Care, Custodial (Part 3, OBC, M-2 Division)</span> </div> |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

X Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

### 1. Submission Sponsor

Mr. Anupam Rai Chief QA Phone: [phone] Email id: [e-mail]

#### SMB Corporation of India,

Plot No. 156 GIDC Umbergaon, Dist. Valsad 396170 Mfg. License No.: MFG/MD/2021/000092

### 2. Primary Correspondent

Mr. Atonu Dutta CEO Phone: [phone] Email: [e-mail]

#### Alceon Medtech Consulting

1008, 10th Floor, "OCEAN", Sarabhai Compound, Near Centre Square mall, Dr. V.S. Marg, Vadodara, Gujarat-390023, India. Phone: [phone]

### 3. Date of preparing the summary

01/05/2024

### 4. Device Details

| Device name (Generic): | Hypodermic Syringe with Needle |
|----------------------------|----------------------------------|
| Device name (Trade Name): | SMB Luer lock disposable syringe |
| Classification Regulation: | 21 CFR 880.5860, 21 CFR 880.5570 |
| Device Class: | Class II |
| Product Code: | FMF, FMI |
| Panel: | General hospital |

{4}------------------------------------------------

### 5. Predicate Device

| Subject Device<br>Manufacturer | Subject Device | Primary Predicate<br>Device 510K | Secondary<br>Predicate Device<br>510K |
|--------------------------------|----------------------------------------------------------|----------------------------------|---------------------------------------|
| SMB<br>Corporation of<br>India | Sterile, Single use<br>Hypodermic Syringe With<br>needle | K202432 | K102584<br>(For Needle) |

### 6. Device Description

The SMB Luer lock disposable syringe is a standard Piston Syringe. It is a two-piece Syringe with male 6% luer lock connection. The Syringe is supplied with Hypodermic Needle having a female 6% luer hub. The Syringe and Needle are supplied sterilized by ETO gas. The device is single use device and non-pyrogenic. The device is available with 2ml Syringe and 23G Needle.

A detailed description of Syringe and Needle is as follows:

Syringe: The Syringe consists of hollow barrel with graduated scale and movable plunger. The barrel has a nozzle with a male luer lock connector that facilitates the connection with female luer lock hub of needle. The graduated scale on the barrel is indicated in the milliliters. The movable plunger is pulled to aspirate and pushed to inject the fluids into barrel.

Needle: The Needle consists of Needle tube, Needle cap. The Needle tube is attached to the Needle hub and the Needle hub is attached to the syringe by luer lock system. A cap is provided to protect Needle sharps protection as well as prevention of injury.

The materials used in manufacturing of Syringe & Needle are safe as demonstrated by the biocompatibility study performed for biological evaluation. Table 1 gives information about raw material.

| Components | Material | Grade | CAS No. | Type of<br>Body<br>Contact |
|------------|---------------|----------|-----------|-----------------------------------------|
| Barrel | Polypropylene | RF830MO | 9010-79-1 | In direct<br>contact with<br>blood path |
| Plunger | HDPE | EHM 6007 | 9002-88-4 | In direct<br>contact with<br>blood path |

Table: 1 Raw Material

{5}------------------------------------------------

| Components | Material | Grade | CAS No. | Type of<br>Body<br>Contact |
|-----------------|-------------------------------------|----------|-----------|-----------------------------------------|
| Needle tube | Stainless steel | SS304 | N/A | Direct<br>contact with<br>blood path |
| Needle hub | Polypropylene<br>(Deep Blue colour) | RF830MO | 9010-79-1 | In direct<br>contact with<br>blood path |
| Needle<br>cover | HDPE | EHM 6007 | 9002-88-4 | No contact |

#### Indication for use:

SMB Hypodermic Syringe is used to inject fluid into or withdraw fluid from the body. This device is for single use only.

## 7. Comparison to a predicate device

| Description | Subject Device<br>(Applied) | Primary Predicate Device<br>(K202432) | Comparison |
|------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|
| Trade/Device<br>Name | SMB Luer lock disposable<br>syringe | MiniLoad Syringe | - |
| Manufacturer | SMB Corporation of India | OcuJect, LLC | - |
| 510 (K) | Applied | K202432 | - |
| Class | Class II | Class II | Same |
| Regulatory<br>number | 21 CFR Part 880.5860 | 21 CFR Part 880.5860 | Same |
| Product code | FMF | FMF | Same |
| Syringe type | Piston Syringe | Piston Syringe | Same |
| Indication for<br>use | SMB Hypodermic Syringe is<br>device that is used to inject<br>fluid into or withdraw fluid<br>from the body. This device is<br>used for single use only. | The MiniLoad Syringe is<br>used to facilitate<br>injections into or<br>withdraw fluids from<br>body. | Same |
| Configuration | Barrel | Barrel | Same |
| | Plunger | Plunger | |
| Materials | | | |
| Description | Subject Device<br>(Applied) | Primary Predicate Device<br>(K202432) | Comparison |
| Barrel | Polypropylene | Polypropylene | Same |
| Plunger | Polyethylene | Polyethylene | Different 1 |
| Lubricant | Silicone oil | Oleamide | Different 1 |
| Principle of<br>operation | Piston Syringe | Piston Syringe | Same |
| Technical specification | | | |
| Barrel Length | $62 \pm 5mm$ | $\sim 85 mm$ | Different 2 |
| Barrel Diameter | $10.30 \pm 0.10mm$ | $\sim 6.4 mm$ | Different 3 |
| Barrel Size<br>(Volume) | 2 ml | 1 ml | Different 4 |
| Plunger Length | $64 \pm 5mm$ | 93.4 | Different 5 |
| Nozzle type | Luer-lock | Slip Tip | Different 6 |
| Graduation | Printed, ISO 7886-1<br>compliant | Printed, ISO 7886-1<br>compliant | Same |
| Barrel<br>transparency | Transparent (Fluid & scale<br>marking clearly visible) | Transparent | Same |
| Reuse durability | Single use only | Single use only | Same |
| Sterilization<br>Method | EO | EO | Same |
| SAL | $10^6$ | $10^6$ | Same |
| Biocompatibility | 1. Cytotoxicity<br>2. Sensitization<br>3. Irritation or<br>Intracutaneous<br>reactivity<br>4. Acute systemic<br>toxicity<br>5. Material mediated<br>pyrogenicity<br>6. Hemocompatibility | 1. Cytotoxicity<br>2. Sensitization<br>3. Irritation or<br>Intracutaneous<br>reactivity<br>4. Acute systemic<br>toxicity<br>5. Material mediated<br>pyrogenicity<br>6. Hemocompatibility | Same |
| Particulate<br>Contamination | Met the USP<788> | Met the USP<788> | Same |
| Label/Labelling | Conform with 21 CFR 801 | Conform with 21 CFR 801 | Same |
| Shelf Life | 5 years | 5 Years | Same |
| Description | Subject Device<br>(Applied) | Secondary Predicate<br>Device<br>(K102584) | Comparison |
| Class | Class II | Class II | Same |
| Regulatory number | 21 CFR Part<br>880.5570 | 21 CFR Part 880.5570 | Same |
| Product code | FMI | FMI | Same |
| Configuration | Needle Hub<br>Needle<br>Needle Cover | Needle Hub<br>Needle<br>Needle Cover | Same |
| Materials | | | |
| Needle Hub | Polypropylene | Polypropylene | |
| Needle | S.S 304 | S.S 304 | Different 7 |
| Needle Cover | HDPE | Polypropylene | |
| Technical specification | | | |
| Needle gauge | 23 G | 16 G to 30 G | Same- (Predicate<br>device have some<br>additional gauge<br>sizes) |
| Nozzle type | Luer-lock | Luer-lock/ Luer-Slip | Same- (Predicate<br>device have<br>additional nozzle<br>type) |
| Needle cover color | Transparent | Transparent | Same |
| Hub/needle bond<br>strength | Complies as per ISO<br>7864:2016 | Complies as per ISO<br>7864:2016 | Same |

### 1. Comparison of Syringe to Predicate Device

{6}------------------------------------------------

{7}------------------------------------------------

### 2. Comparison of Needle to Predicate Device

#### Summary of Substantial Equivalence:

#### Different 1, 7:

The subject and predicate devices contain a similar generic class of materials. However, the exact material grade of the predicate device is not publicly available. There may also be differences in manufacturing and processing aids that may result in a different finished material. Therefore, testing per ISO 10993 and the FDA Guidance "Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing

#### SMB Corporation of India.

{8}------------------------------------------------

within a risk management process" was performed to assess the biological impact of the finished material.

The results of biocompatibility studies were found satisfactory, and we conclude that the materials do not impact the safety and effectiveness of the subject device compared to the predicate device. Hence, the difference can be considered acceptable.

### Different 2, 3, 4, 5:

The intended use of different sizes is the same as the predicate device. The raw material used for the subject device is similar to the predicate device. However, there may be differences in manufacturing and processing that results in a different finished material. Additionally, the device is tested in accordance with the ISO 7886-1:2017, ISO 80369-7:2016, ISO 7864:2016 standards and the results were found satisfactory. Considering these factors, the dimensional difference of barrel & needle does not impact the safety and effectiveness of the subject device when compared to the predicate device. Hence, the difference can be considered acceptable.

#### Different 6:

The predicate Hypodermic Needle is attached to the Hypodermic Syringe by means of lock or push fit (Slip) style. The subject device is attached by means of Luer-lock system. To address this difference, the subject device is tested in accordance with the ISO 7886-1:2017, ISO 80369-7:2016, ISO 7864:2016 standards and the results were found satisfactory. Considering the above difference, it is concluded that Luer-lock system will not result in liquid leakage and prevents accidental removal of needle. Hence, this difference can be considered acceptable.

For the needle cover, different materials were used for the subject device and predicate devices. Testing per ISO 10993 and the FDA Guidance "Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a rick management process" was performed in order to assess the differences in finished material.

The results of biocompatibility were found satisfactory and the material difference does not impact the safety and effectiveness of the subject device when compared to the predicate device. Hence, the difference can be considered acceptable.

### 8. Summary of non-clinical performance data

Non-clinical tests were conducted to verify that the proposed devices met all design specifications. The test results demonstrated that the proposed device complies with the following standards:

{9}------------------------------------------------

| STANDARDS | TEST PARAMETERS |
|---------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ISO 7864:2016 | Sterile hypodermic needles for single use - Requirements and test<br>methods |
| ISO 9626-2016 | Stainless steel needle tubing for the manufacture of medical devices<br>- Requirements and test methods |
| ISO 594-1 | Conical fittings with a 6% (Luer) taper for syringes, needles and<br>certain other medical equipment - Part 1: General requirements |
| ISO 594-2 | Conical fittings with a 6% (Luer) taper for syringes, needles and<br>certain other medical equipment - Part 2: Lock fittings |
| ISO 7886-1:2017 | Sterile hypodermic syringes for single use - Part 1: Syringes for manual<br>use |
| USP 32 NF27 | Sterility |
| USP <85> | Bacterial Endotoxin test |
| USP <788> | Particulate contamination |
| Biocompatibility | |
| ISO 10993-11:2021 | Acute Systemic toxicity |
| ISO 10993-5:2009 | Cytotoxicity |
| ISO 10993-10: 2021 | Skin sensitization study in guinea pigs |
| ISO 10993-10: 2021 | Intracutaneous reactivity test |
| USP-39<br>NF-34,<br>Chapter 151 & ISO<br>10993-11 | Material mediated Pyrogenicity |
| ISO 10993-4 | Hemocompatibility Test |
| ISO 10993-4:2017 | Extract Method |
| ASTM F 756-17 | Direct Contact Method |
| Packaging Test: | |
| ISO 11607-1:2019<br>2nd edition | Packaging for terminally sterilized medical devices - Part 1:<br>Requirements for materials, sterile barrier systems, and packaging<br>systems |
| ISO 11607-2:2019<br>2nd edition | Packaging for terminally sterilized medical devices - Part 2:<br>Validation requirements for forming, sealing, and assembly<br>processes |
| ASTM D4169-16 | Standard Practice for Performance Testing of Shipping Containers<br>and Systems |
| Sterilization Test: | |
| STANDARDS | TEST PARAMETERS |
| ISO<br>11135:2014/AMD<br>1:2018 2nd edition | Sterilization of health care products - Ethylene oxide - Requirements<br>for development, validation, and routine control of a sterilization<br>process for medical devices. |
| EO Residual Test: | |
| ISO 10993-7:2008 | Biological evaluation of medical devices - Part 7: Ethylene oxide<br>sterilization residuals, and it meets the requirements of the<br>standard. |
| Bacterial Endotoxin Test: | |
| USP <85> | The Bacterial endotoxin testing of subject devices was performed by<br>the "Gel-Clot Method" and meets the requirement of USP <85>. |

{10}------------------------------------------------

# 9. Summary of clinical performance data

No clinical data is included in this premarket application submission.

### 10. Conclusion

The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. Based on the comparison and analysis above, the proposed device is determined to be Substantially Equivalent (SE) to the predicate devices.